Latest news
3 December 2020
John Dwyer joins Touchlights board of directors
Hampton, UK – 03 December 2020 – Touchlight, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, today announces the appointment of John Dwyer to the Company’s Board of Directors as a Non-Executive Director. John spent over 20 years as partner at PwC UK, where he led the Global Deals Business and sat … Continued
17 November 2020
Touchlight wins prestigious Lloyds Bank National Business Award
Hampton, UK – 11 November 2020 – Touchlight was announced the winner of The LDC Growth Through Innovation Award at the prestigious 2020 Lloyds Bank National Business Awards, which took place during an online ceremony on 10 November. Commenting on the awards, Jonny Ohlson, Founder and Executive Chairman of Touchlight, said: “It is a privilege to … Continued
15 October 2020
Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services
Former Lonza President of Biologics Manufacturing joins to continue rapid expansion of DNA contract manufacturing Touchlight’s synthetic dbDNA in high demand as starting material in the manufacture of advanced therapies such as mRNA vaccines and cell and gene therapies Hampton, UK – 15 October 2020 Touchlight, a biotechnology company focused on the discovery and development … Continued
29 September 2020
Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture
London, England / Andermatt, Switzerland – 29 September 2020 Touchlight Genetics LLC and Stonehaven Incubate AG have formed a new joint venture company, Touchlight Aquaculture LLC, to combine expertise, intellectual property and platform technology. The new company will utilize Touchlight Genetics’ innovative DNA-based Doggybonetm platform to develop new vaccine solutions, focused on providing solutions exclusively … Continued
21 August 2020
Touchlight announces development of a vaccine against COVID-19
Hampton, London, UK – 21 August 2020 Touchlight is pleased to announce it has begun development of a vaccine against SARS-CoV-2 (COVID-19). Bringing together Touchlight’s technology with a team of vaccine development and infectious and respiratory disease experts, this program seeks to augment the existing vaccine development landscape, guided by emerging clinical data and the … Continued
29 July 2020
Cancer Research UK, University of Southampton and Touchlight Genetics Partner to develop head and neck cancer vaccine
Hampton, London, Southampton, UK – 29 July 2020 Cancer Research UK, the University of Southampton and Touchlight Genetics, a London based biotechnology company, today (Wednesday) announce a new clinical development partnership to progress a therapeutic DNA vaccine, TGL-100, into an early phase clinical trial targeting head and neck squamous cell carcinoma (HNSCC). HNSCC is the … Continued
18 June 2020
Touchlight to develop biobatteries with potential to address limitations of portable power supply
Hampton, UK – 18 June 2020 – Supported by the Office of Naval Research Global (ONR Global) and the Defense Science and Technology Laboratory (DSTL), Touchlight, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, is working together with the Minteer Lab, University of Utah, to develop a DNA-enabled biobattery that could … Continued
5 June 2020
Touchlights’s chairman to help lead UK COVID-19 vaccine effort
Dr. Clive Dix appointed as Deputy Head of the UK’s Vaccine Taskforce Hampton, UK – 5 June 2020 – Touchlight, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, today commented on the news that its Chairman, Dr. Clive Dix, has been appointed Deputy Chair of the UK’s Vaccine Taskforce. In this … Continued
27 April 2020
Touchlight appoints Dr. Helen Horton as Chief Research Officer
Former J&J Senior Scientific Director and immunology expert joins at a pivotal time Touchlight driving its dbDNA technology towards clinical development in therapeutic and prophylactic vaccines Hampton, UK – 27 April 2020 – Touchlight, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, today announces the appointment of Dr. Helen Horton as … Continued
17 January 2019
Touchlight welcomes Anjum Ahmad as Chief Financial Officer
Anjum Ahmad brings extensive insight in the UK’s life sciences sector having been the longstanding Group Finance Director of Touchstone Innovations Plc (formerly Imperial Innovations) – the AIM listed venture capital investor in early stage science. In his former role at Touchstone he was one of the four-person senior executive team, presenting over £200m of … Continued
18 November 2018
Touchlight appoints Dr. Michael Linden as Chief Scientific Officer
Touchlight Genetics Ltd, a biotechnology company focused on the discovery and development of DNA-based genetic medicines, today announced the appointment of Dr. Michael Linden as Chief Scientific Officer (CSO). In his role Dr. Linden will be responsible for leading the Company’s discovery pipeline and translational research efforts in genetic medicine, deploying their doggybone DNA technology … Continued
2 November 2018
Touchlight awarded runner-up in Spectator Economic Disruptor Award
Earlier this year, The Spectator and Julius Baer launched the inaugural Economic Disruptor Awards to celebrate the most creative entrepreneurs in the UK. Over the past six months, over 100 nominations have been reviewed. On the 1st of November, the winners were announced at a gala dinner hosted by Andrew Neil, Chairman of The Spectator, and attended by … Continued